BSEInsider Trading / SAST30 Oct 2026 · 30 Oct 2026, 10:42 am

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Venkaiah Chowdary Nannapaneni

Natco Pharma Ltd · 524816

✦ AI SummaryResults

Natco Pharma Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the allotment of equity shares through a rights issue to eligible equity shareholders. The disclosure includes details of the promoters and members of the promoter group who have acquired shares through the allotment.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Natco Pharma Ltd - 524816 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

29DB7641_EC47_4884_97E7_51B39FB4AE6A_104226.pdf

pdf

Download →
View document text
N atco Pharma Limited Regd. Off. : 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad -500034. Telangana, INDIA. Tel: +91 40 23547532, Fax: +91 40 23548243 CIN: L24230TG1981PLC003201, www.natcopharma.co.in 29th October, 2026 Corporate Relationship Department The Manager - Listing The BSE LTD M/s. National Stock Exchange of India Ltd Mumbai 400 001 Bandra (E) Mumbai 400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir(s), Sub:- Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 & disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 With reference to the above-cited subject, thP. r0n,~;:ir1,' has allotted Equity Shares through Rights Issue to the eligible Equity Shareholders of the Company. In this connection, please find enclosed herewith the (fo,closures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from the following Promoter(s) & Member(s) of the Promoter Group pursuant to allotment of Equity Shares: SI. No. Name of the Promoter(s) & Member(s) of the Promoter No. of Shares acquired Group through allotment 1 Venkaiah Chowdary Nannapaneni 5,86,666 2 Neelima Sita Nannapaneni 2,55,387 3 Rajeev Nannapaneni 58,666 4 VS Swathi Kantamani 61,333 5 KR Kumar 4,761 6 Time Cap Pharma Labs Private Limited 9,33,333 7 Natsoft Information Systems Private Limited 2,40,000 8 Vistra ITCL India Limited A/C Neelima Nannapaneni Trust 69,785 9 Vistra ITCL India Limited A/C VCN Family Trust 161 10 Natco Aqua Limited 1,523 11 SAU Family Trust 161 This is for your information and records. Thanking you Encl: as above. Format for Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 1. Name of the Target Company (TC) NATCO Pharma Limited 2. Name (s) of the acquirer and Persons acting in VENKAIAH CHOWDARY NANNAPANENI Concert (PAC) with the acquirer 3. Whether the acquirer belongs to Promoter/ Promoter Promoter Group 4. Name(s) of the Stock Exchange (s) where the NSE & BSE shares of TC are Listed 5. Details of the acquisition or disposal/holding Number % w.r.t. total % w.r.t. total of shares /voting rights/holding of the acquirer share/voting diluted and PAC capital share/voting wherever capital of applicable the TC(*) Before the acguisitionleisE!esal under consideration, holding of: a) Shares carrying voting rights 2,80,45,905 14.30 14.30 b) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) c) Voting rights (VR) otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) Total (A+B+C+D) 2,80,45,905 14.30 14.30 Details of acguisitionl&ale a) Shares carrying voting rights 5,86,666 0.30 0.30 acquired/seW b) VRs acquired /sold otherwise than by shares c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares encumbered / invoked / released by the acquirer Total (A+B+C+D) 5,86,666 0.30 0.30 After the acquisition/sale, holding of: a) Shares carrying voting rights 2,86,32,571 14.60 14.60 b) Shares encumbered with the acquirer c) VRs otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition Total (A+B+C+D) 2,86,32,571 14.60 14.60 6. Mode of acquisition/ sale (e.g. open Rights Issue market/ off-market/ public issue/ rights issue/ preferential allotment/ inter-se transfer etc). 7. Date of acquisition/ sale of shares/ VR 26/10/2026 or date of receipt of intimation of allotment of shares, whichever is applicable 8. Equity share capital/total voting capital of the TC before the said 17,91,09,870 equity shares of Rs.2/-each acquisition/ sale- 9. Equity share capital/ total voting capital of the TC after the said acquisition/ sale- 19,61,67,952 equity shares of Rs.2/-each 10. Total diluted share/voting capital of the 19,61,67,952 equity shares of Rs.2/-each TC after the said acquisition/sale-. Note:(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. Signature of the Ac:irc eller / l\uthorized Signatory Place: Hyderabad Date: 28-10-2026 FORMC SEBI (Prohibition of Insider Trading) Regulations, 2015 [Regulation 7 (2) read with Regulation 6(2) - Continual disclosure] Name of the Company: Natco Pharma Limited ISIN of the Company: INE987B01026 Details of change in holding of Securities of Promoter, Member of the Promoter Group, Designated Person or Director of a listed company and immediate relatives of such persons and other such persons as mentioned in Regulation 6(2) Name, PAN, CIN/DIN, & Category of Securities held prior to Securities acquired/disposed/pledged Securities held post Date of allotment advice/ Date of Mode of Exch address with contact nos. Person acquisition/disposal/pledg acquisition/disposal/pledg acquisition of shares,Lsale intimation to acquisition/ ange (Promoter/ e e of shaFesfpledge, speeify company disposal (on on member of Type of No. and% of Type of No. Value Transaction Type of No. and %of From To market/public/ whic the security shareholding securit Type (Purchase/ security shareholding rights/ h the promoter (For e.g. y (For Sale/ Pledge/ (For e.g. preferential trade group/desi -Shares, e.g.- Reva eati o At -Shares, offer I off was gnated Warrants Shares, iA•1oeatioAt Warrants market/ Inter- exec person/Dir Warran other please se transfer, uted ector Converti ts, SJ}ei€fy-) Converti ESOPs etc.) s/immediat ble Conver ble e relative Debentur tible Debentur to/others es, rights Debent es, etc.) entitleme ures, rights nts, etc.) rights entitlem entitle ents, ment, etc.) etc.) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) Venkaiah Chowdary Promoter Equity 2,80,45,905 Equity 5,86,666 43,99,99,500 Buy Equity 2,86,32,571 26/10/2026 26/10/2026 28/10/2026 Rights Issue NA Nannapaneni & & Allotment 8-2-293/82/A/530 Road No 14.30% 14.60% 26 Jubilee Hills Hyderabad- 500033, India PAN: ABEPN6301L Contact: 040 23547532 Details of trading in derivatives on the securities of the company by Promoter, member of the promoter group, designated person or Director of a listed company and immediate relatives of such pE!rse>__ns~n~ ot!ier_ such persons as m_en!ion_ed_in ~eg_ul~tio_11612) Trading in derivatives (Specify type of contract, Futures or Options etc.) Exchange on which the trade was executed Type of Contract Contract Buy Sell specifications Notional Value Number of units (contracts* lot size) Notional Value Number of units (contracts * lot size) (16) (17) (18) (19) (20) (21) (22) NA NA NA NA NA NA NA Name: Venkaiah Chowdary Njnnapaneni --------i;:-"~◄111a::C-::,,,Z~:-->-- Signature: Date: 28/10/2026 Designation: Promoter Place: Hyderabad Format for Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 1. Name of the Target Company (TC) NATCO Pharma Limited 2. Name (s) of the acquirer and Persons acting in RAJEEV NANNAPANENI Concert (PAC) with the acquirer 3. Whether the acquirer belongs to Promoter/ Promoter Promoter Group 4. Name(s) of the Stock Exchange (s) where the NSE & BSE shares of TC are Listed 5. Details of the acquisition or disposal/holding Number % w.r.t. total % w.r.t. total of shares /voting rights/holding of the acquirer share/voting diluted and PAC capital share/voting wherever capital of the applicable TC(*) Before the acguisition[elis~esal under conside [Showing first 8,000 characters — download PDF for full document]